Ticker
KURACompany Name
KURA ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Invested Capital | Net Income Common Stock | Return on Invested Capital |
---|---|---|---|
6/30/2025 | $ 324.96M | $ -197.17M | -60.68% |
3/31/2025 | $ 383.76M | $ -181.89M | -47.4% |
12/31/2024 | $ 430.23M | $ -173.98M | -40.44% |
9/30/2024 | $ 440.4M | $ -197.55M | -44.86% |
6/30/2024 | $ 482.8M | $ -181.75M | -37.64% |
3/31/2024 | $ 522.05M | $ -168.09M | -32.2% |
12/31/2023 | $ 414.47M | $ -152.63M | -36.83% |
9/30/2023 | $ 447.36M | $ -142.96M | -31.96% |
6/30/2023 | $ 472.72M | $ -139.86M | -29.59% |
3/31/2023 | $ 408.72M | $ -137.46M | -33.63% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for KURA ONCOLOGY INC is calculated as follows: Net Inc. Cmn. [ $ -81.33M ] / Inv. Capital [ $ 320.02M ]
(=) ROIC [ -25.41% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.36K |
---|---|
min | -46.36% |
max | 48.66% |
average | 0.69% |
median | 3.38% |
std | 15.18% |